Table 1.
Summary of anthocyanin production in engineered bacteria.
E. coli strain |
Genetic modifications | Substrate | Product | Fermentation conditions | Titer/μM | Ref. |
---|---|---|---|---|---|---|
JM109 | MdF3H/AaDFR/MdANS/PhF3GT | 0.25 mM Naringenin | Pelargonidin 3-O-glucoside | M9 minimal medium (pH 7) plus UDP-glucose; IPTG induction at RT |
0.012 | [63] |
0.1 mM Eriodictyol | Cyanidin 3-O-glucoside | 0.012 | ||||
BL21* (DE3) | MdF3H/AaDFR/At3GT/PhANS | 0.2 mM Naringenin | Pelargonidin 3-O-glucoside | M9 minimal medium (pH 7) with 2-oxoglutarate, sodium ascorbate and UDP-glucose; IPTG induction at 30 °C |
1.34 | [39] |
0.2 mM Eriodictyol | Cyanidin 3-O-glucoside | 3.88 | ||||
MdF3H/AaDFR/At3GT/PhANS/DuLAR | 0.2 mM Naringenin | Pelargonidin 3-O-glucoside | 2.09 | |||
0.2 mM Eriodictyol | Cyanidin 3-O-glucoside | 4.27 | ||||
MdF3H/AaDFR/At3GT/PhANS/DuLAR/Dv3MaT | 0.2 mM Naringenin | Pelargonidin 3-O-6″-O-malonylglucoside | 0.18 | |||
0.2 mM Eriodictyol | Cyanidin 3-O-6″-O-malonylglulcoside | 0.21 | ||||
BL21* (DE3) | At3GT/PhANS | 0.75 mM Catechin | Cyanidin 3-O-glucoside | 3 h IPTG induction at 30 °C; 5-fold concentration in M9 minimal medium as listed above without UDP-glucose | 5.16 | |
BL21* (DE3) | At3GT/PhANS | 0.75 mM Catechin | Cyanidin 3-O-glucoside | Concentrated in modified M9 minimal medium (pH 5) | 80 | |
At3GT/PhANS/galU/pgm | 0.75 mM Catechin | Cyanidin 3-O-glucoside | Same as above. | 127 | ||
Fusion of At3GT and PhANS/galU/pgm | 0.75 mM Catechin | Cyanidin 3-O-glucoside | 146 | |||
0.75 mM afzelechin | Pelargonidin 3-O-glucoside | 168 | ||||
BL21* (DE3) | Fusion of At3GT and PhANS/galU/pgm/ndk/Δudg/galE/T(inactive) | Catechin | Cyanidin 3-O-glucoside | Modified M9 medium (pH 5) with orotic acid (0.1 mM) | 215 | [21] |
afzelechin | Pelargonidin 3-O-glucoside | 241 | ||||
BL21* (DE3) | At3GT/PhANS/galU/pgm/cmk/ndk/YadH/ΔtolC | 2.5 mM Catechin | Cyanidin 3-O-glucoside | Modified M9 medium (pH 5) with 1% glucose, 5 mM IPTG, 2-oxoglutarate, sodium ascorbate, and orotic acid. | 260 | [43] |
At3GT/PhANS/galU/pgm/cmk/ndk/ycjU | 2.5 mM Catechin | Cyanidin 3-O-glucoside | 252 | |||
At3GT/PhANS/cmk/ndk/ycjU | 2.5 mM Catechin | Cyanidin 3-O-glucoside | Feed glucose and catechin | 421 | ||
BL21* (DE3) | At3GT/PhANS/galU/pgm/cmk/ndk/ycjU | 2.5 mM Catechin | Cyanidin 3-O-glucoside | Induced at stationary phase; modified M9 medium (pH 5) with 1% glucose, 5 mM IPTG, 2-oxoglutarate, sodium ascorbate, and orotic acid; feed glucose and catechin | 722 | |
BL21* (DE3) | MBP-At3GT/MBP-PhANS/VvAOMT/MetJ↓ (CRISPRi) |
3.44 mM Catechin | Peonidin 3-O-glucoside | Semi-rich medium AMM with 2% glucose, IPTG induction (1 mM) and production process at 30 °C | 112 | [48] |